A practical solid form screen approach to identify a pharmaceutical glutaric acid cocrystal for development

Organic Process Research and Development

Volumn 13, Issue 6, 2009, Pages 1307-1314

  Li, Zhibin ^a   Yang, Bing Shiou ^a   Jiang, Mo ^a   Eriksson, Magnus ^a   Spinelli, Earl ^a   Yee, Nathan ^a   Senanayake, Chris ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72449150123     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op900137j     Document Type: Article

References (36)

1. Blagden, N.; Berry, D. J.; Parkin, A.; Javed, H.; Ibrahim, A.; Gavan, P. T.; De Matos, L. L.; Seaton, C. C. Current directions in co-crystal growth. New J. Chem. 2008, 32 (10), 1659-1672.
2. Trask Andrew, V. An overview of pharmaceutical cocrystals as intellectual property. Mol. Pharm. 2007, 4 (3), 301-309
3. Vishweshwar, P.; McMahon, J. A.; Bis, J. A.; Zaworotko, M. J. Pharmaceutical co-crystals. J. Pharm. Sci. 2006, 95 (3), 499-516.
4. Almarsson, O.; Zaworotko, M. J. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? Chem. Commun. (Cambridge) 2004, 17, 1889-1896.
5. Trask, A. V.; Motherwell, W. D. S.; Jones, W. Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration. Cryst. Growth Des. 2005, 5 (3), 1013-1021.
6. Trask, A. V.; Motherwell, W. D. S.; Jones, W. Physical stability enhancement of theophylline via cocrystallization. Int. J. Pharm. 2006, 320 (1-2), 114-123.
7. McNamara, D. P.; Childs, S. L.; Giordano, J.; Iarriccio, A.; Cassidy, J.; Shet Manjunath, S.; Mannion, R.; O'Donnell, E.; Park, A. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm. Res. 2006, 23 (8), 1888-1897
8. Remenar, J. F.; Morissette, S. L.; Peterson, M. L.; Moulton, B.; MacPhee, J. M.; Guzman, H. R.; Almarsson, O. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. J. Am. Chem. Soc. 2003, 125 (28), 8456-8457.
9. Good, D. J.; Rodriguez-Hornedo, N. Solubility Advantage of Pharmaceutical Cocrystals. Cryst. Growth Des. 2009, 9 (5), 2252-2264.
10. Berry, D. J.; Seaton, C. C.; Clegg, W.; Harrington, R. W.; Coles, S. J.; Horton, P. N.; Hursthouse, M. B.; Storey, R.; Jones, W.; Friscic, T.; Blagden, N. Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients. Cryst. Growth Des. 2008, 8 (5), 1697-1712.
11. Lu, E.; Rodriguez-Hornedo, N.; Suryanarayanan, R. A rapid thermal method for cocrystal screening. CrystEngComm 2008, 10 (6), 665-668.
12. Trask, A. V.; Jones, W. Crystal engineering of organic cocrystals by the solid-state grinding approach. (Organic Solid State Reactions) Top. Curr. Chem. 2005, 254, 41-70.
13. Shan, N.; Toda, F.; Jones, W. Mechanochemistry and co-crystal formation: effect of solvent on reaction kinetics. Chem. Commun. (Cambridge) 2002, 20, 2372-2373.
14. Weyna, D. R.; Shattock, T.; Vishweshwar, P.; Zaworotko, M. J. Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs. Slow Evaporation from Solution. Cryst. Growth Des. 2009, 9 (2), 1106-1123.
15. Basavoju, S.; Bostrom, D.; Velaga Sitaram, P. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. Pharm. Res. 2008, 25 (3), 530-541
16. Takata, N.; Shiraki, K.; Takano, R.; Hayashi, Y.; Terada, K. Cocrystal Screening of Stanolone and Mestanolone Using Slurry Crystallization. Cryst. Growth Des. 2008, 8 (8), 3032-3037.
17. Zhang, G. G. Z.; Henry, R. F.; Borchardt, T. B.; Lou, X. Efficient co-crystal screening using solution-mediated phase transformation. J. Pharm. Sci. 2007, 96 (5), 990-995.
18. Chadwick, K.; Davey, R. J.; Dent, G.; Pritchard, R. G.; Hunter, C. A.; Musumeci, D. Cocrystallization: A Solution Chemistry Perspective and the Case of Benzophenone and Diphenylamine. Cryst. Growth Des. 2009, 9 (4), 1990-1999.
19. Jayasankar, A.; Reddy, L. S.; Bethune, S. J.; Rodriguez-Hornedo, N. Role of Cocrystal and Solution Chemistry on the Formation and Stability of Cocrystals with Different Stoichiometry. Cryst. Growth Des. 2009, 9 (2), 889-897.
20. Rodriguez-Hornedo, N.; Nehm, S. J.; Seefeldt, K. F.; Pagan-Torres, Y.; Falkiewicz, C. J. Reaction Crystallization of Pharmaceutical Molecular Complexes. Mol. Pharm. 2006, 3 (3), 362-367.
21. Remenar, J. F.; Peterson, M. L.; Stephens, P. W.; Zhang, Z.; Zimenkov, Y.; Hickey, M. B. Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential. Mol. Pharm. 2007, 4 (3), 386-400.
22. Simanek, E. E.; Mammen, M.; Gordon, D. M.; Chin, D.; Mathias, J. P.; Seto, C. T.; Whitesides, G. M. Design and synthesis of hydrogenbonded aggregates. Theory and computation applied to three systems based on the cyanuric acid-melamine lattice. Tetrahedron 1995, 51 (2), 607-619
23. Seto, C. T.; Whitesides, G. M. Self-assembly based on the cyanuric acid-melamine lattice. J. Am. Chem. Soc. 1990, 112 (17), 6409-6411
24. Aakeroy, C. B.; Beatty, A. M.; Zou, M. Building organic assemblies with 2-pyridone and dicarboxylic acids: relating molecular conformation and synthon stability to crystal structure. Cryst. Eng. 1999, 1 (3/ 4), 225-241.
25. Bis, J. A.; Vishweshwar, P.; Weyna, D.; Zaworotko, M. J. Hierarchy of Supramolecular Synthons: Persistent Hydroxyl⋯Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor. Mol. Pharm. 2007, 4 (3), 401-416.
26. Oswald, I. D. H.; Motherwell, W. D. S.; Parsons, S.; Pidcock, E.; Pulham, C. R. Rationalisation of co-crystal formation through knowledge-mining. Crystallogr. Rev. 2004, 10 (1), 57-66.
27. Allen, F. H. The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Crystallogr., Sect. B 2002, B58 (3, No. 1), 380-388.
28. Fabian, L. Cambridge Structural Database Analysis of Molecular Complementarity in Cocrystals. Cryst. Growth Des. 2009, 9 (3), 1436-1443.
29. Stahl, H. P., Wermuth, C. G.; Eds. Handbook of Pharmaceutical Salts; Properties, Selection, and Use. 2008; p 374.
30. Friscic, T.; Childs, S. L.; Rizvi, S. A. A.; Jones, W. The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome. CrystEngComm 2009, 11 (3), 418-426.
31. Childs, S. L.; Rodriguez-Hornedo, N.; Reddy, L. S.; Jayasankar, A.; Maheshwari, C.; McCausland, L.; Shipplett, R.; Stahly, B. C. Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine. Cryst-EngComm 2008, 10 (7), 856-864.
32. Karki, S.; Friscic, T.; Jones, W. Control and interconversion of cocrystal stoichiometry in grinding: stepwise mechanism for the formation of a hydrogen-bonded cocrystal. CrystEngComm 2009, 11 (3), 470-481.
33. Nehm, S. J.; Rodriguez-Spong, B.; Rodriguez-Hornedo, N. Phase Solubility Diagrams of Cocrystals Are Explained by Solubility Product and Solution Complexation. Cryst. Growth Des. 2006, 6 (2), 592-600.
34. Gagniere, E.; Mangin, D.; Puel, F.; Bebon, C.; Klein, J.-P.; Monnier, O.; Garcia, E. Cocrystal Formation in Solution: In Situ Solute Concentration Monitoring of the Two Components and Kinetic Pathways. Cryst. Growth Des. 2009, 9 (8), 3376-3383.
35. Gagniere, E.; Mangin, D.; Puel, F.; Rivoire, A.; Monnier, O.; Garcia, E.; Klein, J. P. Formation of co-crystals: Kinetic and thermodynamic aspects. J. Cryst. Growth 2009, 311 (9), 2689-2695.
36. http://www.ich.org/LOB/media/MEDIA423.pdf; Guideline for Residual Solvents (Q3C).